Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Xian-Mei Zhou (Nanjing, China), Xian-Mei Zhou, Dan Wang, Jie Tang. Bone marrow-derived mesenchymal stem cells involve in lymphangiogenesis of lung cancer. Eur Respir J 2016; 48: Suppl. 60, 524

Member's Comments

No comment yet.

Related content which might interest you: Lung stem cells and lung cancer Source: ERS Lung Science Conference 2017 Year: 2017 Impaired migration of bone marrow mesenchymal stem cells in COPD Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Tumor cell-derived osteopontin promotes lung metastasis via both cell-autonomous and paracrine pathways Source: International Congress 2016 – Late-breaking translational research in lung cancer Year: 2016 CD33+CD14-CD11b+CD66b+CD15+VEGFR-1hi myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Abnormal abundance of senescent fibroblasts in the tumor stroma of non-small cell lung cancer patients Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Intratracheal administration of bone marrow-derived mesenchymal stem cells ameliorates lung function Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 The role of Pten in the cell-fate determination of epithelial cells in lung development Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 Correlation of IL-17A concentration with T regulatory cells in lung cancer microenvironment Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Functional impairment of NK cells in non-small-cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Molecular mechanisms of inhibition of lung cancer stem cells invasion by a novel soy isoflavone VF166 Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Neurotrophin TrkB receptor mediates the epithelial to mesenchymal transition in lung adenocarcinoma cells Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Predictors of functional exercise capacity allogeneic hematopoietic stem cell transplantation recipients Source: Annual Congress 2013 –Assessment methods involved in the physiotherapy treatment in different patient populations Year: 2013 Stem cells and lung cancer Source: Eur Respir Monogr 2021; 91: 340-352 Year: 2021 Placenta-derived conditioned medium with anti-tumor properties on human NSCLC Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours Year: 2015 Stem cells, their niches, and evolving concepts concerning cancer Source: Annual Congress 2007 - Stem cells and the lung: the road from basics to clinics Year: 2007 Roles of polarized neutrophils on lung tumour development in an orthotopic lung tumour mouse model Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury Source: Eur Respir J 2009; 34: 740 Year: 2009 Evaluation of lung cancer patients with distant organ metastasis Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Role of insulin and IGF-1 receptors in bronchial epithelial cancer cells Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013